Rapid rituximab administration: Safety of 60-minute infusions in malignant and benign haematological disease.
Whiting R, Misko J, McGuire M, Fox E.
Whiting R, et al.
J Oncol Pharm Pract. 2024 Jun 7:10781552241260863. doi: 10.1177/10781552241260863. Online ahead of print.
J Oncol Pharm Pract. 2024.
PMID: 38847136
Five patients who experienced grade 1-2 infusion reactions with their first or second dose of rituximab safely received 60-min infusions for third and subsequent doses without additional premedication. Indications for treatment included non-Hodgkin's lymphoma (76.99 …
Five patients who experienced grade 1-2 infusion reactions with their first or second dose of rituximab safely received 60-min infusions for …